Bradford T. Whitmore

Insider Reports History

Entity
Individual
Location
5215 Old Orchard Road, Suite 620, Skokie, IL
Signature
Bradford T. Whitmore
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bradford T. Whitmore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NANOPHASE TECHNOLOGIES Corp 10%+ Owner Common Stock 25.4M $38.5M $1.52 Sep 3, 2024 By Whitmore Holdings, LLC
NANOPHASE TECHNOLOGIES Corp 10%+ Owner Common Stock 23.7M $36M $1.52 Sep 3, 2024 By Strandler, LLC
ULTRALIFE CORP Director, 10%+ Owner Common Stock 4.45M $32M $7.19 Sep 3, 2024 By SUNRAY I, LLC
ULTRALIFE CORP Director, 10%+ Owner Common Stock 1.02M $7.34M $7.19 Sep 3, 2024 By Whitmore Holdings, LLC
Clearside Biomedical, Inc. 10%+ Owner Common Stock 4.5M $6.07M $1.35 Feb 7, 2024 Direct
ULTRALIFE CORP Director, 10%+ Owner Common Stock 519K $3.73M $7.19 Sep 3, 2024 By Grace Brothers, LP
Clearside Biomedical, Inc. 10%+ Owner Common Stock 2.35M $3.17M $1.35 Feb 7, 2024 by Grace Brothers, LP
ULTRALIFE CORP Director, 10%+ Owner Common Stock 206K $1.48M $7.19 Sep 3, 2024 Direct
NANOPHASE TECHNOLOGIES Corp 10%+ Owner Common Stock 676K $1.03M $1.52 Sep 3, 2024 By Grace Investments, LP
NANOPHASE TECHNOLOGIES Corp 10%+ Owner Common Stock 108K $164K $1.52 Sep 3, 2024 Direct
Clearside Biomedical, Inc. 10%+ Owner Warrant 444K Feb 7, 2024 Direct
NANOPHASE TECHNOLOGIES Corp 10%+ Owner Series X Preferred Stock 15K Mar 1, 2024 by Strandler, LLC

Insider Reports Filed by Bradford T. Whitmore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ULBI ULTRALIFE CORP Sep 3, 2024 0 $0 4 Sep 3, 2024 Director, 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Sep 3, 2024 0 $0 4 Sep 3, 2024 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Jun 25, 2024 1 $0 4 Jun 26, 2024 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Mar 1, 2024 1 $6M 4 Mar 5, 2024 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Feb 8, 2024 4 $1.53M 4 Feb 12, 2024 10%+ Owner
CLSD Clearside Biomedical, Inc. Feb 7, 2024 2 $600K 4 Feb 9, 2024 10%+ Owner
ULBI ULTRALIFE CORP Dec 6, 2023 2 $111K 4 Dec 8, 2023 Director, 10%+ Owner
ULBI ULTRALIFE CORP Nov 27, 2023 3 $181K 4 Nov 29, 2023 Director, 10%+ Owner
ULBI ULTRALIFE CORP Oct 30, 2023 3 $99K 4 Nov 1, 2023 Director, 10%+ Owner
CLSD Clearside Biomedical, Inc. Oct 30, 2023 3 $99.8K 4 Nov 1, 2023 10%+ Owner
CLSD Clearside Biomedical, Inc. Oct 27, 2023 0 $0 3 Nov 1, 2023 10%+ Owner
ULBI ULTRALIFE CORP Sep 13, 2023 3 $112K 4 Sep 15, 2023 Director, 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Aug 21, 2023 3 $78.9K 4 Aug 23, 2023 10%+ Owner
ULBI ULTRALIFE CORP Jun 12, 2023 3 $398K 4 Jun 14, 2023 Director, 10%+ Owner
ULBI ULTRALIFE CORP Jun 2, 2023 1 $26.2K 4 Jun 5, 2023 Director, 10%+ Owner
ULBI ULTRALIFE CORP May 30, 2023 3 $146K 4 Jun 1, 2023 Director, 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp May 30, 2023 3 $19.3K 4 Jun 1, 2023 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp May 17, 2023 3 $56.2K 4 May 19, 2023 10%+ Owner
ULBI ULTRALIFE CORP May 9, 2023 3 $117K 4 May 11, 2023 Director, 10%+ Owner
ULBI ULTRALIFE CORP Mar 9, 2023 3 $122K 4 Mar 13, 2023 Director, 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Dec 15, 2022 1 $331K 4/A Dec 16, 2022 10%+ Owner
ULBI ULTRALIFE CORP Dec 14, 2022 3 $152K 4 Dec 16, 2022 Director, 10%+ Owner
ULBI ULTRALIFE CORP Dec 6, 2022 3 $279K 4 Dec 8, 2022 Director, 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Dec 6, 2022 3 $213K 4 Dec 8, 2022 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Nov 16, 2022 3 $185K 4 Nov 18, 2022 10%+ Owner
ULBI ULTRALIFE CORP Aug 17, 2022 2 $158K 4 Aug 19, 2022 Director, 10%+ Owner
ULBI ULTRALIFE CORP Aug 2, 2022 3 $467K 4 Aug 4, 2022 Director, 10%+ Owner
ULBI ULTRALIFE CORP Jun 6, 2022 2 $219K 4 Jun 8, 2022 Director, 10%+ Owner
ULBI ULTRALIFE CORP Feb 24, 2022 3 $245K 4 Feb 28, 2022 Director, 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp Dec 21, 2021 2 $0 4 Dec 23, 2021 10%+ Owner
ULBI ULTRALIFE CORP Dec 17, 2021 1 $297K 4 Dec 20, 2021 Director, 10%+ Owner
CLSD Clearside Biomedical, Inc. Aug 30, 2021 3 -$2.92M 4 Sep 1, 2021 10%+ Owner
ULBI ULTRALIFE CORP Aug 2, 2021 3 $199K 4 Aug 4, 2021 Director, 10%+ Owner
NANX NANOPHASE TECHNOLOGIES Corp May 7, 2021 2 $1.62M 4 May 11, 2021 10%+ Owner